You are hereForums / General Discussions / Bimatoprost/Timolol in Glaucoma and Ocular Hypertension
Bimatoprost/Timolol in Glaucoma and Ocular Hypertension
The combination drug bimatoprost/timolol (marketed as Ganfort®) comprises the synthetic prostamide bimatoprost and the β-adrenergic receptor antagonist timolol.
According to this review, Bimatoprost/timolol (one drop administered in the affected eye[s] once daily in the morning or evening) is an effective and well tolerated fixed combination for lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension (OHT), including individuals uncontrolled on monotherapy with a β-adrenergic receptor antagonist or prostaglandin analogue/prostamide.
Therapeutic Efficacy:
